chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity, Pruritus, Somnolence
Clinical narrative: pain in extremity; redness; hot; swelling; itching; somnolence; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in extremity), ERYTHEMA (redness), FEELING HOT (hot), SWELLING (swelling) and PRURITUS (itching) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in extremity), ERYTHEMA (redness), FEELING HOT (hot), SWELLING (swelling), PRURITUS (itching) and SOMNOLENCE (somnolence). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 30-Mar-2021, PAIN IN EXTREMITY (pain in extremity) had resolved. At the time of the report, ERYTHEMA (redness), FEELING HOT (hot), SWELLING (swelling), PRURITUS (itching) and SOMNOLENCE (somnolence) had not resolved. Not Provided          Concomitant medications details were not reported by the reporter.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: pain in extremity; redness; hot; swelling; itching; somnolence; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in extremity), ERYTHEMA (redness), FEELING HOT (hot), SWELLING (swelling) and PRURITUS (itching) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in extremity), ERYTHEMA (redness), FEELING HOT (hot), SWELLING (swelling), PRURITUS (itching) and SOMNOLENCE (somnolence). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 30-Mar-2021, PAIN IN EXTREMITY (pain in extremity) had resolved. At the time of the report, ERYTHEMA (redness), FEELING HOT (hot), SWELLING (swelling), PRURITUS (itching) and SOMNOLENCE (somnolence) had not resolved. Not Provided          Concomitant medications details were not reported by the reporter.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Headache, Myalgia, Vomiting
Clinical narrative: abdominal pain; headache; vomiting; body aches; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (abdominal pain), HEADACHE (headache), VOMITING (vomiting) and MYALGIA (body aches) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 06-Dec-2020. Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN), MULTIVITAMINS [VITAMINS NOS] and PROGESTERONE for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced ABDOMINAL PAIN (abdominal pain), HEADACHE (headache), VOMITING (vomiting) and MYALGIA (body aches). At the time of the report, ABDOMINAL PAIN (abdominal pain), HEADACHE (headache), VOMITING (vomiting) and MYALGIA (body aches) outcome was unknown.            Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-065501 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-065501:Dose 1
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Tiny bump; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Tiny bump) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Cancer (cancer survivor). Concurrent medical conditions included Diabetes and Blood pressure high. Concomitant products included VITAMINS NOS for Supplementation therapy, GLIPIZIDE, SEMAGLUTIDE (OZEMPIC), LOSARTAN and AMLODIPINE for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced SWELLING (Tiny bump). On 05-Mar-2021, SWELLING (Tiny bump) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling hot, Headache, Peripheral swelling, Rhinorrhoea
Clinical narrative: runny nose; swelling on my arm; hot areas on my arm; headache; chills; sneezing; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (sneezing), RHINORRHOEA (runny nose), PERIPHERAL SWELLING (swelling on my arm), FEELING HOT (hot areas on my arm) and HEADACHE (headache) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 028A212) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced SNEEZING (sneezing), PERIPHERAL SWELLING (swelling on my arm), FEELING HOT (hot areas on my arm), HEADACHE (headache) and CHILLS (chills). On an unknown date, the patient experienced RHINORRHOEA (runny nose). On 31-Mar-2021, CHILLS (chills) outcome was unknown. At the time of the report, SNEEZING (sneezing), RHINORRHOEA (runny nose), PERIPHERAL SWELLING (swelling on my arm), FEELING HOT (hot areas on my arm) and HEADACHE (headache) outcome was unknown.            No concomitant medication provided. No treatment medication provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: runny nose; swelling on my arm; hot areas on my arm; headache; chills; sneezing; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (sneezing), RHINORRHOEA (runny nose), PERIPHERAL SWELLING (swelling on my arm), FEELING HOT (hot areas on my arm) and HEADACHE (headache) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 028A212) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced SNEEZING (sneezing), PERIPHERAL SWELLING (swelling on my arm), FEELING HOT (hot areas on my arm), HEADACHE (headache) and CHILLS (chills). On an unknown date, the patient experienced RHINORRHOEA (runny nose). On 31-Mar-2021, CHILLS (chills) outcome was unknown. At the time of the report, SNEEZING (sneezing), RHINORRHOEA (runny nose), PERIPHERAL SWELLING (swelling on my arm), FEELING HOT (hot areas on my arm) and HEADACHE (headache) outcome was unknown.            No concomitant medication provided. No treatment medication provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling hot, Injection site mass, Injection site pruritus
Clinical narrative: lump at injection site; injection site arm itched; fever of 101 degrees Farenheight in the morning.; sore arm; face hot to touch; chills; fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), FEELING HOT (face hot to touch), INJECTION SITE MASS (lump at injection site), INJECTION SITE PRURITUS (injection site arm itched) and CHILLS (chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included IBUPROFEN for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), FEELING HOT (face hot to touch), CHILLS (chills), PYREXIA (fever) and FATIGUE (fatigue). On 17-Mar-2021, the patient experienced INJECTION SITE MASS (lump at injection site), INJECTION SITE PRURITUS (injection site arm itched) and PYREXIA (fever of 101 degrees Farenheight in the morning.). At the time of the report, PAIN IN EXTREMITY (sore arm), FEELING HOT (face hot to touch), INJECTION SITE MASS (lump at injection site), INJECTION SITE PRURITUS (injection site arm itched), CHILLS (chills), PYREXIA (fever), FATIGUE (fatigue) and PYREXIA (fever of 101 degrees Farenheight in the morning.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: lump at injection site; injection site arm itched; fever of 101 degrees Farenheight in the morning.; sore arm; face hot to touch; chills; fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), FEELING HOT (face hot to touch), INJECTION SITE MASS (lump at injection site), INJECTION SITE PRURITUS (injection site arm itched) and CHILLS (chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included IBUPROFEN for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), FEELING HOT (face hot to touch), CHILLS (chills), PYREXIA (fever) and FATIGUE (fatigue). On 17-Mar-2021, the patient experienced INJECTION SITE MASS (lump at injection site), INJECTION SITE PRURITUS (injection site arm itched) and PYREXIA (fever of 101 degrees Farenheight in the morning.). At the time of the report, PAIN IN EXTREMITY (sore arm), FEELING HOT (face hot to touch), INJECTION SITE MASS (lump at injection site), INJECTION SITE PRURITUS (injection site arm itched), CHILLS (chills), PYREXIA (fever), FATIGUE (fatigue) and PYREXIA (fever of 101 degrees Farenheight in the morning.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Had surgery in February so was unable to received second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Had surgery in February so was unable to received second dose) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20X1) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Had surgery in February so was unable to received second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Had surgery in February so was unable to received second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  This report refers to a case of product dose omission issue for mRNA-1273, lot # 042L20X1  with no associated AEs.; Sender's Comments: This report refers to a case of product dose omission issue for mRNA-1273, lot # 042L20X1  with no associated AEs.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Very slight sore arm) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Very slight sore arm). At the time of the report, PAIN IN EXTREMITY (Very slight sore arm) outcome was unknown. Not Provided. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were not provided. Treatment medications was not provided. This case was linked to MOD-2021-065504.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Mobility decreased, Myalgia, Palpitations
Clinical narrative: skin turns colors; heart racing; could not lay down; cold chills; severe headache; severe body aches; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (skin turns colors), PALPITATIONS (heart racing), MOBILITY DECREASED (could not lay down), CHILLS (cold chills) and HEADACHE (severe headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19. Concomitant products included MULTIVITAMINS [VITAMINS NOS], BUPROPION HYDROCHLORIDE (WELLBUTRIN), PROGESTERONE and CITALOPRAM for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 26-Feb-2021, the patient experienced SKIN DISCOLOURATION (skin turns colors), PALPITATIONS (heart racing), MOBILITY DECREASED (could not lay down), CHILLS (cold chills), HEADACHE (severe headache) and MYALGIA (severe body aches). At the time of the report, SKIN DISCOLOURATION (skin turns colors), PALPITATIONS (heart racing), MOBILITY DECREASED (could not lay down), CHILLS (cold chills), HEADACHE (severe headache) and MYALGIA (severe body aches) outcome was unknown.            The patient notes that she was tested positive in 06Dec2020 and four weeks later she was tested positive for antibodies. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-065491 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-065491:Dose 2
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration
Clinical narrative: skin turns colors; heart racing; could not lay down; cold chills; severe headache; severe body aches; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (skin turns colors), PALPITATIONS (heart racing), MOBILITY DECREASED (could not lay down), CHILLS (cold chills) and HEADACHE (severe headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19. Concomitant products included MULTIVITAMINS [VITAMINS NOS], BUPROPION HYDROCHLORIDE (WELLBUTRIN), PROGESTERONE and CITALOPRAM for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 26-Feb-2021, the patient experienced SKIN DISCOLOURATION (skin turns colors), PALPITATIONS (heart racing), MOBILITY DECREASED (could not lay down), CHILLS (cold chills), HEADACHE (severe headache) and MYALGIA (severe body aches). At the time of the report, SKIN DISCOLOURATION (skin turns colors), PALPITATIONS (heart racing), MOBILITY DECREASED (could not lay down), CHILLS (cold chills), HEADACHE (severe headache) and MYALGIA (severe body aches) outcome was unknown.            The patient notes that she was tested positive in 06Dec2020 and four weeks later she was tested positive for antibodies. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-065491 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-065491:Dose 2
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 years old received the 1st dose of Moderna COVID19 vaccine on 03/10/2021; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 years old received the 1st dose of Moderna COVID19 vaccine on 03/10/2021) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 years old received the 1st dose of Moderna COVID19 vaccine on 03/10/2021). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 years old received the 1st dose of Moderna COVID19 vaccine on 03/10/2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  No treatment information was provided.  This report refers to a case of Inappropriate age at vaccine administration  for mRNA-1273, lot # 032M20A with no associated AEs.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Non-Significant Follow-up appended on 15-JUN-2021; Sender's Comments: This report refers to a case of Inappropriate age at vaccine administration  for mRNA-1273, lot # 032M20A with no associated AEs.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Tinnitus
Clinical narrative: dizziness; weird clicking sound when I would move my head; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), TINNITUS (weird clicking sound when I would move my head) and FATIGUE (Fatigue) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     The patient's past medical history included Dizziness and Fatigue.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), TINNITUS (weird clicking sound when I would move my head) and FATIGUE (Fatigue). At the time of the report, DIZZINESS (dizziness), TINNITUS (weird clicking sound when I would move my head) and FATIGUE (Fatigue) outcome was unknown.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-065484 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-065484:1st dose vaccine
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Little bit more sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little bit more sore arm) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Little bit more sore arm). At the time of the report, PAIN IN EXTREMITY (Little bit more sore arm) outcome was unknown. Not Provided          No treatment medication information were not provided No concomitant medication  were not provided Action taken with mRNA-1273 in response to the event was not applicable.     This case was linked to MOD-2021-065500 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No events; This spontaneous case was reported by a non-health professional and describes the occurrence of NO ADVERSE EVENT (No events) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Allergy to SULFA), Iodine allergy, Hypertension and Hypothyroidism. Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (HYZAAR) and AMLODIPINE BESILATE (NORVASC) for Blood pressure high, LEVOTHYROXINE for Thyroid disorder, CALCIUM and VITAMIN D NOS for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NO ADVERSE EVENT (No events). At the time of the report, NO ADVERSE EVENT (No events) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       patient has no problems with first dose.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Updated concurrent medical conditions which includes Drug allery(sulfa),iodine allergy,Hypertension and Hypothyroidism. Updated the vaccine information which includes the details of first and second dose. Added concomitant medications used. Updated the event details with the outcome of the events recovered/resolved. On 15-Jul-2021: Follow-up received on 15-JUL-2021 has No New Information
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: severe migraine; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (severe migraine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced MIGRAINE (severe migraine). At the time of the report, MIGRAINE (severe migraine) outcome was unknown.            No concomitant medication provided no treatment medication provided
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: Bad allergies; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Bad allergies) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 216B21A) for COVID-19 vaccination. No Medical History information was reported. On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Bad allergies). At the time of the report, HYPERSENSITIVITY (Bad allergies) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient's medical history included unspecified medical conditions. No relevant concomitant medications were reported. No treatment information was provided.
Age: 17.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 year old patient was inadvertently given a first dose of Moderna; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient was inadvertently given a first dose of Moderna) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient was inadvertently given a first dose of Moderna). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient was inadvertently given a first dose of Moderna) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.  This report refers to a case of Product administered to patient of Inappropriate age for mRNA-1273, lot # unknown, with no associated AEs.; Sender's Comments: This report refers to a case of Product administered to patient of Inappropriate age for mRNA-1273, lot # unknown, with no associated AEs.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tested positive for COVID; This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (tested positive for COVID) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (tested positive for COVID). At the time of the report, COVID-19 (tested positive for COVID) outcome was unknown. Not applicable    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information were reported by the reporter
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Few hives on my legs; Rash all over; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Few hives on my legs) and RASH (Rash all over) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced URTICARIA (Few hives on my legs) and RASH (Rash all over). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, URTICARIA (Few hives on my legs) and RASH (Rash all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: fever; achy; tired; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), PAIN (achy) and FATIGUE (tired) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), PAIN (achy) and FATIGUE (tired). At the time of the report, PYREXIA (fever), PAIN (achy) and FATIGUE (tired) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 100.4 (High) 100.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medication was available. No Treatment Medication was available.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Injection site erythema, Injection site induration, Injection site warmth, Vomiting
Clinical narrative: warm to touch at injection site; hard at injection site; Injection site is red, size is 2 and half inches in diameter; extremely bad vomiting; extremely bad diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (warm to touch at injection site), DIARRHOEA (extremely bad diarrhea), INJECTION SITE INDURATION (hard at injection site), INJECTION SITE ERYTHEMA (Injection site is red, size is 2 and half inches in diameter) and VOMITING (extremely bad vomiting) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced DIARRHOEA (extremely bad diarrhea) and VOMITING (extremely bad vomiting). On an unknown date, the patient experienced INJECTION SITE WARMTH (warm to touch at injection site), INJECTION SITE INDURATION (hard at injection site) and INJECTION SITE ERYTHEMA (Injection site is red, size is 2 and half inches in diameter). On 24-Mar-2021, DIARRHOEA (extremely bad diarrhea) and VOMITING (extremely bad vomiting) had resolved. At the time of the report, INJECTION SITE WARMTH (warm to touch at injection site), INJECTION SITE INDURATION (hard at injection site) and INJECTION SITE ERYTHEMA (Injection site is red, size is 2 and half inches in diameter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment information were not reported by the reporter.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Exposure during pregnancy, Ultrasound scan, Underdose
Clinical narrative: Pregnant; Drop from syringe/related to type of syringe; Few drops of the vaccine dripped out of the syringe/few drips of vaccine drip down my arm/whoops some dripped.; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant), DEVICE CONNECTION ISSUE (Drop from syringe/related to type of syringe) and UNDERDOSE (Few drops of the vaccine dripped out of the syringe/few drips of vaccine drip down my arm/whoops some dripped.) in a 33-year-old female patient (gravida 4, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 030A21A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from November 2020 to an unknown date for Pregnancy.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 27-Jul-2021. On 31-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant), DEVICE CONNECTION ISSUE (Drop from syringe/related to type of syringe) and UNDERDOSE (Few drops of the vaccine dripped out of the syringe/few drips of vaccine drip down my arm/whoops some dripped.). On 31-Mar-2021, DEVICE CONNECTION ISSUE (Drop from syringe/related to type of syringe) and UNDERDOSE (Few drops of the vaccine dripped out of the syringe/few drips of vaccine drip down my arm/whoops some dripped.) had resolved. At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, Ultrasound scan: normal (normal) Normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was unknown.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Follow-up information received on 11-Jun-2021, updated vaccine facility name, patient height and event description.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Urticaria
Clinical narrative: getting red itchy bumps on the bottom of feet, heel, toes, and mainly on the palm of hand with a few bumps on top of thu; bumps situated at the joints so she's can't curl her finger because it hurts; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), URTICARIA (getting red itchy bumps on the bottom of feet, heel, toes, and mainly on the palm of hand with a few bumps on top of thu) and URTICARIA (bumps situated at the joints so she's can't curl her finger because it hurts) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 27-Mar-2021, the patient experienced URTICARIA (getting red itchy bumps on the bottom of feet, heel, toes, and mainly on the palm of hand with a few bumps on top of thu) and URTICARIA (bumps situated at the joints so she's can't curl her finger because it hurts). At the time of the report, PAIN IN EXTREMITY (sore arm), URTICARIA (getting red itchy bumps on the bottom of feet, heel, toes, and mainly on the palm of hand with a few bumps on top of thu) and URTICARIA (bumps situated at the joints so she's can't curl her finger because it hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment information were reported by the reporter.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Feeling abnormal, Heart rate, Tachyarrhythmia
Clinical narrative: When she went back to bet, got a tremendous irregular tachycardia; Felt awful and felt she was going to die; Awful pain in middle of chest; Difficulty breathing; This spontaneous case was reported by a health care professional and describes the occurrence of TACHYARRHYTHMIA (When she went back to bet, got a tremendous irregular tachycardia), FEELING ABNORMAL (Felt awful and felt she was going to die), CHEST PAIN (Awful pain in middle of chest) and DYSPNOEA (Difficulty breathing) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included Weight loss (unexplained weight loss during pandemic). Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), ALENDRONATE SODIUM (ALENDRONATE) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced TACHYARRHYTHMIA (When she went back to bet, got a tremendous irregular tachycardia), FEELING ABNORMAL (Felt awful and felt she was going to die), CHEST PAIN (Awful pain in middle of chest) and DYSPNOEA (Difficulty breathing). On 01-Apr-2021, TACHYARRHYTHMIA (When she went back to bet, got a tremendous irregular tachycardia), FEELING ABNORMAL (Felt awful and felt she was going to die), CHEST PAIN (Awful pain in middle of chest) and DYSPNOEA (Difficulty breathing) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2021, Heart rate: high (High) Very strength pulse. This lasted for about 20 minutes. and normal (normal) Normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not applicable.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 18-Jul-2021: Follow-up information received on 19-Jul-2021 and included updated information on concomitant medications, action taken, event onset and event stop date and primary dosage information. The medical history, lab test added and event feeling abnormal verbatim was updated.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Coronavirus test positive
Clinical narrative: tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of CORONAVIRUS TEST POSITIVE (tested positive for COVID) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030AZ1A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced CORONAVIRUS TEST POSITIVE (tested positive for COVID). At the time of the report, CORONAVIRUS TEST POSITIVE (tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Mar-2021, COVID-19: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment information were reported by the reporter.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Neck mass
Clinical narrative: lump on the right side of the neck; chills; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of NECK MASS (lump on the right side of the neck), CHILLS (chills) and FATIGUE (felt tired) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NECK MASS (lump on the right side of the neck), CHILLS (chills) and FATIGUE (felt tired). At the time of the report, NECK MASS (lump on the right side of the neck), CHILLS (chills) and FATIGUE (felt tired) outcome was unknown.            She is taking medicine for cholesterol.  No concomitant medications were reported. Treatment details were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Eye swelling, Hypersensitivity, Pruritus, Urticaria
Clinical narrative: She's having an allergic reaction; My eyes are swelled; I'm having hives on different parts of my body; ears are hot; itchy ears; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (She's having an allergic reaction), EYE SWELLING (My eyes are swelled), URTICARIA (I'm having hives on different parts of my body), ERYTHEMA (ears are hot) and PRURITUS (itchy ears) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced HYPERSENSITIVITY (She's having an allergic reaction), EYE SWELLING (My eyes are swelled), URTICARIA (I'm having hives on different parts of my body), ERYTHEMA (ears are hot) and PRURITUS (itchy ears). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (She's having an allergic reaction), EYE SWELLING (My eyes are swelled), URTICARIA (I'm having hives on different parts of my body), ERYTHEMA (ears are hot) and PRURITUS (itchy ears) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient states that symptoms seem to be getting worse as time passes. Treatment medication include:Ice   Reporter did not allow further contact
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of peripheral swelling (right swollen arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Mar 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 11, 2021, patient experienced peripheral swelling (right swollen arm). At the time of the report, peripheral swelling (right swollen arm): unresolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant product use and treatment information not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain at the injection site). At the time of the report, VACCINATION SITE PAIN (Pain at the injection site) outcome was unknown. Not Provided          Treatment information was not provided. Concomitant medications were not reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site rash
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site discolouration (injection site black and blue) and vaccination site rash (big red ring, rash like, below injection site, raised area but now is just red) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 007B21A) for COVID-19 immunization. Concomitant products included Prozac (fluoxetine hydrochloride) for an unknown indication. On Mar 22, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 23, 2021, patient experienced vaccination site discolouration (injection site black and blue) and vaccination site rash (big red ring, rash like, below injection site, raised area but now is just red). At the time of the report, vaccination site discolouration (injection site black and blue) and vaccination site rash (big red ring, rash like, below injection site, raised area but now is just red): unresolved. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown. Other concomitant medicine: Vitamins.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hot flush
Clinical narrative: Redness on the face; The face feels hot; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness on the face) and HOT FLUSH (The face feels hot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced ERYTHEMA (Redness on the face) and HOT FLUSH (The face feels hot). At the time of the report, ERYTHEMA (Redness on the face) and HOT FLUSH (The face feels hot) outcome was unknown.            No concomitant and treatment information were reported by the reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Photosensitivity reaction, Vaccination site erythema, Vaccination site pain
Clinical narrative: photosensitivity reaction; redness 1x2 inches in size; injection site area was painful; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOSENSITIVITY REACTION (photosensitivity reaction), VACCINATION SITE PAIN (injection site area was painful) and VACCINATION SITE ERYTHEMA (redness 1x2 inches in size) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included Pneumonia. Concurrent medical conditions included Iodine allergy and Allergy (fish, beef, and seafood).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE PAIN (injection site area was painful). On 31-Mar-2021, the patient experienced PHOTOSENSITIVITY REACTION (photosensitivity reaction) and VACCINATION SITE ERYTHEMA (redness 1x2 inches in size). At the time of the report, PHOTOSENSITIVITY REACTION (photosensitivity reaction), VACCINATION SITE PAIN (injection site area was painful) and VACCINATION SITE ERYTHEMA (redness 1x2 inches in size) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.